Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients

被引:6
作者
Niparuck, Pimjai [1 ]
Kanoksil, Wasana
Chuncharunee, Suporn [1 ]
Boonsakan, Paisarn
Ungkanont, Artit [1 ]
Angchaisuksiri, Pantep [1 ]
Karntisaviwat, Kanlaya [2 ]
Apilugsanachit, Axara [2 ]
Rerkamnuatchoke, Budsaba [2 ]
Jootar, Saengsuree [1 ]
Nitiyanant, Prawat
Atichartakarn, Vichai [1 ]
机构
[1] Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
[2] Mahidol Univ, Dept Pathol, Ramathibodi Hosp, Div Human Genet, Bangkok 10700, Thailand
关键词
RITUXIMAB;
D O I
10.3109/10428194.2010.505675
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2120 / 2125
页数:6
相关论文
共 8 条
  • [1] Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)
    Byrd, JC
    Peterson, BL
    Morrison, VA
    Park, K
    Jacobson, R
    Hoke, E
    Vardiman, JW
    Rai, K
    Schiffer, CA
    Larson, RA
    [J]. BLOOD, 2003, 101 (01) : 6 - 14
  • [2] Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the, cytotoxic activity of either drug alone
    Di Gaetano, N
    Xiao, Y
    Erba, E
    Bassan, R
    Rambaldi, A
    Golay, J
    Introna, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) : 800 - 809
  • [3] Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha
    McLaughlin, P
    Estey, E
    Glassman, A
    Romaguera, J
    Samaniego, F
    Ayala, A
    Hayes, K
    Maddox, AM
    Preti, HA
    Hagemeister, FB
    [J]. BLOOD, 2005, 105 (12) : 4573 - 4575
  • [4] Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma
    Misgeld, E
    Germing, U
    Aul, C
    Gattermann, N
    [J]. LEUKEMIA RESEARCH, 2001, 25 (01) : 95 - 98
  • [5] Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an intergroup study, cancer and leukemia group B 9011
    Morrison, VA
    Rai, KR
    Peterson, BL
    Kolitz, JE
    Elias, L
    Appelbaum, FR
    Hines, JD
    Shepherd, L
    Larson, RA
    Schiffer, CA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 3878 - 3884
  • [6] TAM SC, 2006, HEMATOLOGICA, V91, P1546
  • [7] Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia
    Wierda, W
    O'Brien, S
    Wen, S
    Faderl, S
    Garcia-Manero, G
    Thomas, D
    Do, KA
    Cortes, J
    Koller, C
    Beran, M
    Ferrajoli, A
    Giles, F
    Lerner, S
    Albitar, M
    Kantarjian, H
    Keating, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4070 - 4078
  • [8] Yamauchi T, 2001, CLIN CANCER RES, V7, P3580